EOM Pharmaceutical Holdings, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/18 Q2

ended 03/31/18 Q1

ended 12/31/17 FY 2017

ended 09/30/17 Q3

Late quarterly filing notification for Q3 2017

Prospectuses and Registrations Filter

Registration withdrawal request

Initial registration of new securities – amended

Exempt offering of securities

Initial registration of new securities – amended

Initial registration of new securities

Ownership Filter

Intracoastal Capital, LLC

Empery Asset Management, LP

Intracoastal Capital, LLC

Empery Asset Management, LP

News Filter

ImmunoCellular Announces Receipt of Notice of Noncompliance With the NYSE American Continued Listing Standards

ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants

ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results

ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results

ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary revised proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC